127 related articles for article (PubMed ID: 36715495)
1. Adverse late health outcomes among children treated with 3D radiotherapy techniques: Study design of the Dutch pediatric 3D-RT study.
Beijer JGM; Kok JL; Janssens GO; Streefkerk N; de Vries ACH; Slagter C; Maduro JH; Kroon PS; Grootenhuis MA; van Dulmen-den Broeder E; Loonen JJ; Wendling M; Tissing WJE; van der Pal HJ; Louwerens M; Bel A; den Hartogh J; van der Heiden-van der Loo M; Kremer LCM; Teepen JC; Ronckers CM
Cancer Rep (Hoboken); 2023 Feb; 6(2):e1620. PubMed ID: 36715495
[TBL] [Abstract][Full Text] [Related]
2. Long-term toxic effects of proton radiotherapy for paediatric medulloblastoma: a phase 2 single-arm study.
Yock TI; Yeap BY; Ebb DH; Weyman E; Eaton BR; Sherry NA; Jones RM; MacDonald SM; Pulsifer MB; Lavally B; Abrams AN; Huang MS; Marcus KJ; Tarbell NJ
Lancet Oncol; 2016 Mar; 17(3):287-298. PubMed ID: 26830377
[TBL] [Abstract][Full Text] [Related]
3. Late toxicity following craniospinal radiation for early-stage medulloblastoma.
Christopherson KM; Rotondo RL; Bradley JA; Pincus DW; Wynn TT; Fort JA; Morris CG; Mendenhall NP; Marcus RB; Indelicato DJ
Acta Oncol; 2014 Apr; 53(4):471-80. PubMed ID: 24564687
[TBL] [Abstract][Full Text] [Related]
4. Incidence of and Risk Factors for Histologically Confirmed Solid Benign Tumors Among Long-term Survivors of Childhood Cancer.
Kok JL; Teepen JC; van der Pal HJ; van Leeuwen FE; Tissing WJE; Neggers SJCMM; Loonen JJ; Louwerens M; Versluys B; van den Heuvel-Eibrink MM; van Dulmen-den Broeder E; Jaspers MMW; van Santen HM; van der Heiden-van der Loo M; Janssens GO; Maduro JH; Bruggink AH; Jongmans MC; Kremer LCM; Ronckers CM;
JAMA Oncol; 2019 May; 5(5):671-680. PubMed ID: 30920605
[TBL] [Abstract][Full Text] [Related]
5. Radiobiological risk estimates of adverse events and secondary cancer for proton and photon radiation therapy of pediatric medulloblastoma.
Brodin NP; Munck Af Rosenschöld P; Aznar MC; Kiil-Berthelsen A; Vogelius IR; Nilsson P; Lannering B; Björk-Eriksson T
Acta Oncol; 2011 Aug; 50(6):806-16. PubMed ID: 21767178
[TBL] [Abstract][Full Text] [Related]
6. Temporal patterns in the risk of chronic health conditions in survivors of childhood cancer diagnosed 1970-99: a report from the Childhood Cancer Survivor Study cohort.
Gibson TM; Mostoufi-Moab S; Stratton KL; Leisenring WM; Barnea D; Chow EJ; Donaldson SS; Howell RM; Hudson MM; Mahajan A; Nathan PC; Ness KK; Sklar CA; Tonorezos ES; Weldon CB; Wells EM; Yasui Y; Armstrong GT; Robison LL; Oeffinger KC
Lancet Oncol; 2018 Dec; 19(12):1590-1601. PubMed ID: 30416076
[TBL] [Abstract][Full Text] [Related]
7. Risk and determinants of low and very low bone mineral density and fractures in a national cohort of Dutch adult childhood cancer survivors (DCCSS-LATER): a cross-sectional study.
van Atteveld JE; de Winter DTC; Pluimakers VG; Fiocco M; Nievelstein RAJ; Hobbelink MGG; de Vries ACH; Loonen JJ; van Dulmen-den Broeder E; van der Pal HJ; Pluijm SMF; Kremer LCM; Ronckers CM; van der Heiden-van der Loo M; Versluijs AB; Louwerens M; Bresters D; van Santen HM; Olsson DS; Hoefer I; van den Berg SAA; den Hartogh J; Tissing WJE; Neggers SJCMM; van den Heuvel-Eibrink MM;
Lancet Diabetes Endocrinol; 2023 Jan; 11(1):21-32. PubMed ID: 36513116
[TBL] [Abstract][Full Text] [Related]
8. Questionnaire- and linkage-based outcomes in Dutch childhood cancer survivors: Methodology of the DCCSS LATER study part 1.
Teepen JC; Kok JL; Feijen EAM; Loonen JJ; van den Heuvel-Eibrink MM; van der Pal HJ; Tissing WJE; Bresters D; Versluys B; Grootenhuis MA; Louwerens M; Neggers SJCMM; van Santen HM; de Vries A; Janssens GO; den Hartogh JG; van Leeuwen FE; Hollema N; Streefkerk N; Kilsdonk E; van der Heiden-van der Loo M; van Dulmen-den Broeder E; Ronckers CM; Kremer LCM;
Cancer Med; 2023 Mar; 12(6):7588-7602. PubMed ID: 36519590
[TBL] [Abstract][Full Text] [Related]
9. Treatment planning with protons for pediatric retinoblastoma, medulloblastoma, and pelvic sarcoma: how do protons compare with other conformal techniques?
Lee CT; Bilton SD; Famiglietti RM; Riley BA; Mahajan A; Chang EL; Maor MH; Woo SY; Cox JD; Smith AR
Int J Radiat Oncol Biol Phys; 2005 Oct; 63(2):362-72. PubMed ID: 16168831
[TBL] [Abstract][Full Text] [Related]
10. Late Morbidity and Mortality Among Medulloblastoma Survivors Diagnosed Across Three Decades: A Report From the Childhood Cancer Survivor Study.
Salloum R; Chen Y; Yasui Y; Packer R; Leisenring W; Wells E; King A; Howell R; Gibson TM; Krull KR; Robison LL; Oeffinger KC; Fouladi M; Armstrong GT
J Clin Oncol; 2019 Mar; 37(9):731-740. PubMed ID: 30730781
[TBL] [Abstract][Full Text] [Related]
11. Clinical evaluation of late outcomes in Dutch childhood cancer survivors: Methodology of the DCCSS LATER 2 study.
Feijen EAM; Teepen JC; van Dulmen-den Broeder E; van den Heuvel-Eibrink MM; van der Heiden-van der Loo M; van der Pal HJH; de Vries ACH; Louwerens M; Bresters D; Versluys B; de Ridder H; Veening M; van Leeuwen FE; Grootenhuis M; Maurice-Stam H; van Santen HM; Neggers SJCMM; Pluijm S; den Hartogh J; Ronckers CM; Tissing WJE; Loonen JJ; Kremer LCM
Pediatr Blood Cancer; 2023 May; 70(5):e30212. PubMed ID: 36651687
[TBL] [Abstract][Full Text] [Related]
12. Effectiveness and Cost-Effectiveness of Survivorship Care for Survivors of Hodgkin Lymphoma (INSIGHT Study): Protocol for a Multicenter Retrospective Cohort Study With a Quasi-Experimental Design.
Lammers EMJ; Zijlstra JM; Retèl VP; Aleman BMP; van Leeuwen FE; Nijdam A;
JMIR Res Protoc; 2024 Apr; 13():e55601. PubMed ID: 38635308
[TBL] [Abstract][Full Text] [Related]
13. Long-term neurologic health and psychosocial function of adult survivors of childhood medulloblastoma/PNET: a report from the Childhood Cancer Survivor Study.
King AA; Seidel K; Di C; Leisenring WM; Perkins SM; Krull KR; Sklar CA; Green DM; Armstrong GT; Zeltzer LK; Wells E; Stovall M; Ullrich NJ; Oeffinger KC; Robison LL; Packer RJ
Neuro Oncol; 2017 May; 19(5):689-698. PubMed ID: 28039368
[TBL] [Abstract][Full Text] [Related]
14. The risk of secondary cancer in pediatric medulloblastoma patients due to three-dimensional conformal radiotherapy and intensity-modulated radiotherapy.
Sherif RS; Elshemey WM; Attalla EM
Indian J Cancer; 2018; 55(4):372-376. PubMed ID: 30829273
[TBL] [Abstract][Full Text] [Related]
15. Late effects of childhood cancer treatment in long-term survivors diagnosed before the age of 3 years - A multicenter, nationwide study.
Latoch E; Zubowska M; Młynarski W; Stachowicz-Stencel T; Stefanowicz J; Sławińska D; Kowalczyk J; Skalska-Sadowska J; Wachowiak J; Badowska W; Czajńska-Deptuła A; Dembowska-Bagińska B; Garus K; Skoczeń S; Pobudejska-Pieniążek A; Szczepański T; Machnik K; Panasiuk A; Sęga-Pondel D; Malesza I; Raciborska A; Zielezińska K; Urasiński T; Mizia-Malarz A; Wawrzeńczyk A; Karolczyk G; Kołtan A; Wysocki M; Wołowiec M; Matysiak M; Krawczuk-Rybak M
Cancer Epidemiol; 2022 Oct; 80():102209. PubMed ID: 35868173
[TBL] [Abstract][Full Text] [Related]
16. Rationale and design of a cohort study on primary ovarian insufficiency in female survivors of Hodgkin's lymphoma: influence on long-term adverse effects (SOPHIA).
Krul IM; Opstal-van Winden AWJ; Zijlstra JM; Appelman Y; Schagen SB; Meijboom LJ; Serné E; Lambalk CB; Lips P; van Dulmen-den Broeder E; Hauptmann M; Daniëls LA; Aleman BMP; van Leeuwen FE
BMJ Open; 2018 Sep; 8(9):e018120. PubMed ID: 30206072
[TBL] [Abstract][Full Text] [Related]
17. Out-of-field doses in pediatric craniospinal irradiations with 3D-CRT, VMAT, and scanning proton radiotherapy: A phantom study.
Majer M; Ambrožová I; Davídková M; De Saint-Hubert M; Kasabašić M; Knežević Ž; Kopeć R; Krzempek D; Krzempek K; Miljanić S; Mojżeszek N; Veršić I; Stolarczyk L; Harrison RM; Olko P
Med Phys; 2022 Apr; 49(4):2672-2683. PubMed ID: 35090187
[TBL] [Abstract][Full Text] [Related]
18. Clinical characteristics of subsequent histologically confirmed meningiomas in long-term childhood cancer survivors: A Dutch LATER study.
Verbruggen LC; Kok JL; Teepen JC; Janssens GO; de Boer CM; Stalpers LJA; Vernooij MW; van Dulmen-den Broeder E; Loonen JJ; van den Heuvel-Eibrink MM; Tissing WJE; van der Heiden-van der Loo M; Versluys AB; Neggers SJCMM; van Leeuwen FE; Hoving EW; Wesseling P; Kremer LCM; Ronckers CM; van der Pal HJH;
Eur J Cancer; 2021 Jun; 150():240-249. PubMed ID: 33934061
[TBL] [Abstract][Full Text] [Related]
19. Late Toxicity After 3-Dimensional External Beam Radiotherapy Among Children With Cancer: A Systematic Review.
Beijer JGM; Teepen JC; Streefkerk N; Heijnen RM; Janssens GO; Kremer LCM; van Dalen EC; Ronckers CM
J Pediatr Hematol Oncol; 2022 May; 44(4):117-134. PubMed ID: 35398857
[TBL] [Abstract][Full Text] [Related]
20. What Are Risk Factors for and Outcomes of Late Amputation After Treatment for Lower Extremity Sarcoma: A Childhood Cancer Survivor Study Report.
Geiger EJ; Liu W; Srivastava DK; Bernthal NM; Weil BR; Yasui Y; Ness KK; Krull KR; Goldsby RE; Oeffinger KC; Robison LL; Dieffenbach BV; Weldon CB; Gebhardt MC; Howell R; Murphy AJ; Leisenring WM; Armstrong GT; Chow EJ; Wustrack RL
Clin Orthop Relat Res; 2023 Mar; 481(3):526-538. PubMed ID: 35583517
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
